Martin A. Mattingly's most recent trade in TRACON Pharmaceuticals Inc was a trade of 15,750 Director Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 14, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| TRACON Pharmaceuticals Inc | Martin A. Mattingly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 15,750 | 15,750 | - | - | Director Stock Option (Right to Buy) | |
| Achieve Life Sciences Inc. | Martin A. Mattingly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 4,400 | 4,400 | - | - | Stock Option (right to buy) | |
| TRACON Pharmaceuticals Inc | Martin A. Mattingly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 10,500 | 10,500 | - | - | Director Stock Option (Right to Buy) | |
| Achieve Life Sciences Inc. | Martin A. Mattingly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2021 | 3,750 | 3,750 | - | - | Stock Option (right to buy) |